Skip to main content
M

MICRO-X LIMITED — Investor Relations & Filings

Ticker · MX1 ISIN · AU000000MX15 ASX Manufacturing
Filings indexed 669 across all filing types
Latest filing 2021-10-18 Regulatory Filings
Country AU Australia
Listing ASX MX1

About MICRO-X LIMITED

https://www.micro-x.com

Micro-X Limited specializes in the development and commercialization of innovative X-ray products utilizing proprietary carbon nanotube (CNT) cold cathode technology. This technology enables the miniaturization of X-ray sources, allowing for the creation of lightweight, portable, and highly efficient imaging systems. The company's product portfolio includes the Nano and Rover mobile medical X-ray units designed for bedside and field hospital use, and the Argus X-ray camera for high-resolution security and counter-IED applications. Micro-X is also developing advanced solutions for airport security through self-service checkpoints and portable head CT scanners for rapid stroke diagnosis in pre-hospital environments. By replacing traditional, bulky thermionic X-ray tubes with electronic CNT emitters, the company provides enhanced mobility and digital precision across medical, defense, and security markets.

Recent filings

Filing Released Lang Actions
Becoming a substantial holder 3 pages 84.0KB
Regulatory Filings
2021-10-18 English
MX1 - Notice of Annual General Meeting/Proxy Form 51 pages 801.9KB
Regulatory Filings
2021-10-14 English
Micro-X Cleansing Statement 2 pages 115.2KB
Regulatory Filings
2021-10-07 English
Notification regarding unquoted securities - MX1 7 pages 29.9KB
Regulatory Filings
2021-10-06 English
Change of Director's Interest Notice - Peter Rowland 3 pages 187.8KB
Regulatory Filings
2021-10-06 English
Application for quotation of securities - MX1 7 pages 29.2KB
Regulatory Filings
2021-10-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.